The RCVS has appointed Amanda Boag as its new Treasurer, replacing Dr Bradley Viner who will become (junior) Vice-President in July.
Amanda will officially take up her post at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 11 July.
Amanda is a Clinical Director at Vets Now and is also currently President of the European Society of Veterinary Emergency and Critical Care. She was elected to RCVS Council for a four-year term in 2012.
As Treasurer she will be responsible for maintaining an overview of the College's affairs, ensuring its financial viability and making sure that proper financial records and procedures are maintained.
Amanda said: "I am very honoured to have been appointed Treasurer for the RCVS and am looking forward to working closely with other Council members and the Belgravia House team.
"I would particularly like to thank my predecessor Bradley Viner for the excellent work he has done over the past four years. This has been a period of great change for the College and during his tenure he has done a huge amount of work to support the improvements in governance, including standardising the way that the College's accounts are reported.
"Our finances are currently in a healthy state despite no increase in the annual renewal fee for several years. I am now looking forward to building on his legacy and ensuring the finances remain healthy, allowing us to move forward with our Strategic Plan."
At RCVS Day on 11 July, Professor Stuart Reid will also be confirmed as President; current President Neil Smith as (senior) Vice-President; Chris Tufnell as Chairman of the Education Committee; and David Catlow as Chairman of the Standards Committee.
The company is now asking farm vets to point their clients in the direction of the FarmComm study and encourage them to take part, share their thoughts and help shape the way we all work together in the future.
Mat Yarnall, senior brand manager at Boehringer said: "With routine visits, practice meetings, herd or flock health planning sessions and farming shows and exhibitions all on-hold, how vets work with their clients is subject to change on a scale never seen before.
“The study is striving to understand what methods of working going forward may work, what won’t work and how people want to work.”
The FarmComm study will be being sent out directly to farmers or can be accessed at https://bit.ly/farm-comm.
Matt added: "Following analysis and interpretation, these findings will be shared with vets as we all move together into new and different times."
Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).
Dechra says these therapies have targeted modes of action and therefore are often more effective, provide an extended duration of activity and have fewer side effects, all of which help to extend and improve the quality of life for companion animals while decreasing the care burden for pet owners.
Jesper Nordengaard, Chief Executive Officer of Dechra, said: "I regard this acquisition as hugely important for Dechra, marking the start of a new chapter in our growth.
"It demonstrates our ambition to create further points of differentiation and relevance with veterinarians and pet owners alike, confidence in our ability to deliver highly innovative new products, and capacity to execute large scale transactions at speed."
Jesper added: “The half-life extension technology developed by Invetx allows for the generation of therapeutics that make treatment of chronic conditions far more convenient for pet owners and veterinarians through improved compliance.
"The pipeline of products currently being developed are all high value potential and will deepen our expertise in core therapeutic areas such as atopic dermatitis and osteoarthritis, allowing for synergistic product development, sales & marketing, and education efforts in the future.”
https://www.invetx.com
Vetoquinol has launched Rimifin® a non-steroidal anti-inflammatory drug (NSAID) for dogs, containing carprofen. Carprofen can reduce inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. It can also be used as a follow-up to parenteral analgesia in the management of post-operative pain following soft tissue surgery. Rimifin® is available in a range of tablet sizes, 20mg, 50mg and 100mg. A single 100mg tablet can treat a 50kg dog.
VetCell is celebrating a win at Cheltenham, after 'Knowhere' won the Cotswold Chase following pioneering stem cell treatment for a serious tendon injury.
Knowhere had had a good start to his racing career as a four-year-old, winning his first two races as a novice hurdler. But after his second race in 2004 he suffered injuries to both forelimb superficial digital flexor tendons. The left fore showed low grade tendonitis while the right fore had a significant percentage of fibre rupture. As a promising racing prospect, Knowhere’s connections wanted to give him the best possible chance of recovering from his injury so they opted for stem cell therapy. He was treated by Tim Beauregard MRCVS of Summerhill Farm in Gloucestershire.
Bone marrow samples were collected from Knowhere’s sternum and were processed in VetCell's laboratory over a five week period to generate millions of stem cells. Knowhere was sedated, the tendon area was anaesthetised and the leg was then surgically clipped and disinfected. Stem cells, which had been suspended in serum obtained from the original bone marrow sample, were then injected using ultrasound guidance, into the core of the damaged area of the tendon fibres.
For the first week after the implantation Knowhere was kept in his stable to allow the cells to adapt to their new environment. Each day after this he was given walking exercise in order to stimulate the activity of the stem cells, encouraging them to differentiate into tendon cells and form into strong tendon fibres. The amount of exercise was incrementally increased, building up over a three-month period from five minutes each day to 45 minutes twice a day.
By the autumn of 2005 both of Knowhere’s tendons had healed very well and showed good fibre pattern on ultrasonography. He was re-introduced to the racetrack the following year and of the 15 or so races he has been in since, he has finished in the frame on eight occasions and has amassed some £175,000 in winnings.
Vet Tim Beauregard said: “Knowhere’s successful return to the track has been exciting and immensely satisfying to follow and he showed particularly brilliant form in the Cotswold Chase. It remains to be seen whether he will be heading for the Ryanair Chase, the Gold Cup or the Grand National but all involved will be hoping for the best.”
For more information please contact VetCell on +44 207 691 2062 or 866 764 0340, email: info@vetcell.com or visit the website at http://www.vetcell.com/
According to Intervet, a study undertaken in Germany last summer has proven the efficacy of Butox SWISH at killing the midges responsible for carrying the bluetongue virus, when applied monthly to cattle. The study showed that even brief contact between a midge and hair from a treated animal killed midges rapidly for up to four weeks post-treatment.
The standard dose, applied in the usual way (on the neck and topline of the animal) delivers full-body coverage of Butox SWISH’s deltamethrin, helped partly by its unique micronised formulation. The product is also highly lipophilic which means it binds onto the natural oil secretions of the coat helping to improve coverage.
The trial used six heifers (each weighing around 400kg) treated with 30ml Butox SWISH (the standard fly dose and method of application). Two un-treated heifers were also studied for comparison.
During the five week period, contact between midges and treated hair caused immediate paralysis, and the midges then died at varying intervals depending on contact time and the number of days post-treatment with Butox SWISH. The trial verified the application of Butox SWISH monthly at the standard dose for cattle.
Trial director, Professor Mehlhorn suggested that producers should be prepared to reduce vector contact by removing their breeding habitats and combining this with the use of a knock-down treatment like Butox SWISH, which is the only product of its type which has proven efficacy against midges. Used in conjunction with vaccination, these measures may not stop the disease entering the herd, but will help reduce the spread of disease.
The new Aberdeen clinic will be based at Ardene House Veterinary Hospital, Kingswells in Aberdeen and will provide the out-of-hours cover for a number of veterinary practices in the Aberdeen area, treating their clients' pets at nights, weekends and bank holidays.
Vets Now was founded in 2001 when vet Richard Dixon, saw a gap in the market for not only providing an alternative to the 'on call' service which vets are required to provide by the Royal College of Veterinary Surgeons, but to providing a dedicated emergency service for pets, similar to A & E for humans. Vets Now now treats around 100,000 small animal emergencies every year with clinic teams working purely out-of-hours, to ensure that they are always fresh and ready to provide life saving treatment to pets who are injured or critically ill.
Richard said: "Vets Now has a clinic in Edinburgh and we have recently opened the first of our Vets Now Hospitals in Glasgow which combines emergency care with a range of specialist referral options, serving the whole of Scotland so we're looking forward hugely to extending our service in Scotland by bringing the dedicated emergency service to Aberdeen."
Vets Now will be working with Ardene House Veterinary Hospital, Abervet, Ashgrove Veterinary Centre, Bridge Veterinary Group and Swan Veterinary Practice to deliver their Out Of Hours emergency care.
Veterinary practices who would like to find out more about using the new Vets Now service in Aberdeen should contact Vets Now on 01383 620064.
Petplan has been named the UK's Best Pet Insurance Provider at the Consumer Moneyfacts awards.
Voted for by over 17,000 consumers, the awards recognise the best financial products available to consumers in the UK.
Petplan, which says it has recently strengthened its policies to provide pet owners with more comprehensive cover, was chosen by consumers for its market leading policies and outstanding customer service.
Petplan Director Neil Brettell said: "The award is great recognition for the fantastic job that our team at Petplan does to keep pets healthy and owners happy.
"Our Covered for Life policies truly do what they say, they ensure that a pet can get the best possible treatment throughout its life without the owner having to worry about the cost. It's great to be recognised for the service that we've been providing to the nation's pets for over 35 years."
For information about how working with Petplan can help your practice call Vetline on 0800 316 8800 or visit www.petplanvet.co.uk
Axiom Veterinary Laboratories and Woodley Equipment Company have announced a partnership which the companies say will mean they can offer a comprehensive solution encompassing referral laboratory services and in-house diagnostic testing, with significant cost savings for practices.
Steve Clarke, Business Development and Marketing Manager for Axiom said: "After an exhaustive search we believe that we have found a partner in Woodley that shares our drive and ambition in delivering a first class solution to practices along with service backup. We offer a cost-effective, quality service with flexibility, fast turnaround times including a free of charge courier service across many parts of the UK and Ireland. We believe that in the current economic climate it is an ideal time for practices to review both their referral laboratory service and their in-house equipment provision."
Mike Wickham, Managing Director of Woodley Equipment Company added: "We offer a wide range of equipment, tailored to the size of the practice, workload and specialty. In partnering with Axiom Veterinary Laboratories we are able to offer a complete package including exclusive and very competitive discount structures for practices.
Both companies with be exhibiting at the forthcoming WSAVA conference in Birmingham (Axiom stand 418 and Woodley Equipment Company stand 718).
Vétoquinol - maker of Epiphen, the anti-epileptic phenobarbital for the control of epilepsy in dogs - has added a new client brochure and a fridge magnet to its Epiphen support packs, designed to help owners understand the condition and make it easier for them to comply with daily dosage requirements.
The new brochure is called What I need to know and is written for clients that have been prescribed Epiphen for their pet for the first time.
Abbie King, Product Manager for Epiphen, said: ''The inspiration for the new brochure came after spending time at the Animal Health Trust in Newmarket and realising how much information an owner needs to take in when their dog is diagnosed with epilepsy."
The new brochure covers the important information owners need to help them understand and manage their dog's epilepsy, including how Epiphen works, what they can do to help their dog, how to monitor seizures, where to find further information and frequently asked questions.
The Epiphen Treatment fridge magnet is designed as a quick reference guide to prescribing information that is needed every day when living with a dog with epilepsy. The magnet leaves space for the owner to write in their dog's name, dosage details and timings and their vet's phone number. Vétoquinol says it is especially helpful as a reference if more than one person is caring for the dog.
The new items enhance the existing Epiphen support pack, which comprises an owner manual, medication record and seizure diary, dog tags, seizure report pads, free serum level monitoring vouchers and a free, online resource at www.epiphenonline.co.uk
Vétoquinol also invites practitioners who are dealing with challenging cases to take advantage of its free Ask the expert scheme on 0800 169 8197 or email a case history to epiphen@vetoquinol.co.uk.
To order the new Epiphen support materials, ring 0800 1698197. Alternatively, visit: www.vetoquinol.co.uk to find out more.
Two award-winning independent practices, Glasgow-based Pets’n’Vets and Fife-based Inglis Vets, have joined forces to launch what they describe as a pioneering new graduate training programme.
The new.graduatevet programme (or ‘Dot’ programme) provides hands-on surgical training at Inglis Vets' in Cowdenbeath, seminars from Advanced Veterinary Practitioners at the Pets'n'Vets’ Roundhouse Veterinary Hospital in Glasgow and a new website accessible to all new and recent graduates: www.new.graduatevet.co.uk
Inglis Vets senior vet Graeme Eckford (pictured left, above), said: "This innovation has seen Scotland’s two leading independent vets, Inglis and The Pets’n’Vets Family, bring our considerable combined expertise and facilities together to create what we believe to be the best well-rounded, supported and unique new graduate training programme available in Scotland.
"Support is delivered through an integrated mentor system, peer-to-peer learning opportunities and regular case reviews, with the Dot programme designed to integrate with, and augment, the PDP requirements."
Ross Allan, a partner in The Pets‘n’Vets Family (pictured right, above), said: "The Dot programme will see the new graduates undertake advanced training and extra practice on surgery, consultations and general practice to accelerate their surgical skills and confidence at Inglis Vets ‘Care and Save’– Cowdenbeath before attending the Pets'n'Vets Roundhouse Veterinary Hospital in Glasgow’s Southside for a digest of seminars.
"We are proud to work with Inglis Vets to develop the programme which we believe will provide a platform for new graduates to apply the skills they’ve learned at university throughout the previous five years, and allow them to excel in their careers.
"We believe this exciting new venture demonstrates the willingness of progressive independent veterinary practices to work constructively together to allow both our new graduate vets, and in turn our practices, to thrive. There will be considerable opportunities for the new graduate vets when they have completed their training in the 16 practices which comprise our two ground-breaking vet practices."
The new.graduatevet website has been established to run alongside the new.graduatevet programme as an online mentor and with the aim of providing a community and learning space for all new and recent graduate vets; a much-needed resource for the next generation of vet graduates. Its range of blogs, news and advice on a range of relevant topics are available to all.
New veterinary graduates can apply for a place on the Dot programme by logging onto www.new.graduatevet.co.uk
If you're in London before January 6th 2008, the Animal's War exhibition at the Imperial War Museum might be worth a visit. Sponsored by The Kennel Club and PetPartners, the family exhibition explores the remarkable role of animals in conflict from the First World War to the present day using hands-on interactives, photographs, film and sound clips, paintings, touchable sculptures, and memorabilia from the Imperial War Museum collections and private and public lenders from all over the world.
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Siemens will be showcasing its range of technology for veterinary care, from advanced ultrasound, CT and MRI systems to haematological and immunological diagnostics at BSAVA Congress.
The company says MRI and CT are starting to become more influential in the veterinary field. MRI provides a reliable veterinary imaging method when traditional procedures such as X-ray and ultrasound are not able to convey the detail needed. They display small changes in bone and soft tissue and can be complemented with special adjustments such as mini coils for dog and cat paws to make them suitable for application with animals. This allows vets to diagnose more accurately and treat specific complaints. The images produced by MRI systems can be used for tumour diagnosis, nervous complaints or orthopaedic problems as well as intestinal, respiratory or cardiovascular disorders.
Siemens will also be presenting its in vitro range of solutions and assays in chemistry, haematology and immunology.
This will include the IMMULITE® range, a blood testing platform which the company says has an unrivalled immunoassay portfolio, allowing the rapid diagnosis of a broad spectrum of small animal conditions.
Information on the ADVIA® 2120i Haematology System with specific animal software and Dimension® Xpand® Plus integrated chemistry and immunoassay system will also be available.
Product literature and in-depth discussions with Siemens specialists will be available from the stand during the event.
Denise Coston of Castle Veterinary Surgeons in Durham has won The Veterinary Business Journal Practice Manager of the Year 2011, and praised the award for promoting her role.
Denise, who was a manager at Lloyds TSB's lending centre and previously ran her own business, before joining Castle Vets three years ago, said: "I did not find out that I had been nominated until three weeks before the ceremony - it was totally out of the blue. To make it to the final three was brilliant, but to win was just incredible.
Denise also said the Practice Manager of the Year Award plays a vital part in promoting the role of practice managers to the wider industry: "It is so important in recognising and championing the efforts of practice managers. I'm sure there will be many people out there who still don't know what we do or how we could benefit their business and this award highlights our achievements.
"This is an evolving role and it is often a case of matching what each practice needs, but I think the fact that there is an award highlights the point that there is true value in having a practice manager."
Editor of The Veterinary Business Journal Robin Fearon said: "Denise is a deserving winner of the title Practice Manager of the Year because she understands the importance of helping to define business strategy for the practice, and I wish her every success in future."
Two new Postgraduate Deans have been appointed by the Royal College of Veterinary Surgeons to advise and monitor new veterinary surgeons during their Professional Development Phase (PDP), the first stage in veterinary continuing professional development.
Jill Hubbard, a partner at Cibyn Veterinary Surgery, Caernarfon, and organiser of BVA North Wales' young graduate meetings, and Nicky Paull, a former BVA President with extensive experience of running veterinary practices and understanding of the needs of veterinary graduates, were selected from over 40 applicants. They join existing Deans, Professor Agnes Winter and Julian Wells, and replace Professor David Noakes and Stephen Ware, who are retiring from the role having served since 2007, when PDP first became a requirement for veterinary graduates.
Jill Hubbard said: "I have always had a particular interest in how we support and guide our new graduates. This seemed a way of being actively involved - a useful niche to try and fill."
Nicky Paull said: "The development of young veterinary graduates has been of special interest to me for some years. In employing young veterinary surgeons, meeting recent graduates through my political work and the time spent with undergraduates through extra-mural studies and the Society of Practising Veterinary Surgeons' final year student seminars, I'm aware of the need for help and guidance for development of the young vets who are joining our profession."
The PDP applies to every newly qualified veterinary surgeon. It consists of an online record which the vet completes, and which is signed off by a Postgraduate Dean. This helps new vets and their employers check that sufficient experience is being gained so that the vet can progress from the 'Day-One competencies' of a new graduate to those expected of a vet with about a year's in-practice experience.
The International Federation on Ageing has published Companion Animals and the Health of Older Persons, a report described as the most extensive literature review to date of research undertaken in the field of companion animals and the health of older people, made possible through an educational sponsorship from Bayer Healthcare.
The report provides a comprehensive literature review into the ways pets contribute to the physical and mental health of individuals and the well-being of our broader society, citing studies which found:
Dr Jane Barratt from the International Federation on Ageing said: "This field of research has important implications across generations and also for the future of our broader society. Many studies have broadly discussed how pets, such as dogs and cats, contribute to health by reducing anxiety, loneliness and depression, but until today, have not yet been published in a single resource. This new report advances our understanding of the value of companion animals in the framework of human health and the broader society."
In the report, investigators acknowledge that the current data on human-companion animal interactions are often predicated on anecdotal evidence and scant qualitative and quantitative data, with poorly-constructed and poorly-controlled study design. This may account in part for the conflicting results found in a number of different studies. Nonetheless, they argue that based on current evidence of considerable positive potential for the health of older individuals, and the associated health and welfare benefits for local communities and societies, more research time and energy should be directed towards this area of research. In particular, they say, there should be much greater involvement from veterinary surgeons, who are well placed to be consulted in studies of companion animals and older people’s attachment, affection and bonding capacities, well-being and social capital.
Ferenc Polz, Head of Bayer Animal Health said: "The therapeutic benefit of companion animals is an area of study attracting increasing interest among health and social science professionals and this sponsored report is yet another example of the life changing potential of human and animal relationships."
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
Amanda originally studied and worked in Australia where she undertook a residency in small animal medicine at Murdoch University, completing a Masters in respiratory medicine in dogs.
She moved to the UK in 2016 to work in referral medicine, joining Hamilton Specialist Referrals in 2024 as head of its medicine service.
The webinar will include a refresher on the bacterial, fungal, parasitic and protozoal causes of lower respiratory tract disease and its pathology, after which it will look at techniques and methods for diagnosis.
Amanda's presentation will also look at the secondary effects of infectious lower respiratory disease pathogens, and prescribing and management options.
https://horiba.link/respiratory-disease-in-dogs-and-cats
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
Dechra Veterinary Products is offering vets free Identichips® worth £100 when they order Equipalazone® Powder 100s. The European Union (EU) has now approved regulations that any equine foal born after July 1 2009 should be micro-chipped, and Defra is currently consulting with equine industry professionals about the best method of implementation. The combination of a micro-chip and horse passport provides a reliable method of identification and also a medical record. Larry King, Dechra's equine product manager said: "We want to make it easier for vets to offer clients the best method of identification and in turn, make it difficult for horses treated with veterinary medicines to enter the human food chain. "We are pleased to support the micro-chipping initiative and the Equine Passport Scheme with our Identichips offer and an owner leaflet about passports to promote responsible horse ownership. They will both help prevent important products like Equipalazone from inadvertently entering the food chain. He added: "We stand to lose up to 70 per cent of veterinary medicines if the industry and horse owners don't comply with EU legislation of horse passports and micro-chipping for every equine". The owner leaflet outlines the importance and benefits of the Equine Passport Scheme and is being inserted into every box of Equipalazone Powder 100s. Further copies are available from Dechra Veterinary Products for practices to distribute to their clients. Practices can claim their free Identichips by ordering boxes of Equipalazone Powder 100s from Rachel Horton at Dechra Veterinary Products on 01743 452 847 before August 31 2008.
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Freda Andrews, the Director of Education at the RCVS, has announced her retirement from the position on 2nd April after nearly 16 years at the College.
Freda joined the RCVS as Head of Education in September 1999 and became Director of Education in 2013, with strategic responsibility for both veterinary and veterinary nursing education.
Nick Stace, RCVS Chief Executive Officer, said: "We will miss Freda for her professionalism, her encyclopaedic knowledge of all things related to veterinary education and her attention to detail, but she leaves behind a team that is stronger-than-ever and a considerable legacy for the profession as a whole.
"Under her watch the Education Department has seen a significant number of achievements. This includes the introduction of the Professional Development Phase which has helped veterinary graduates develop their confidence and competence during the first few years of practice and the accreditation of the University of Nottingham's School of Veterinary Medicine and Science - the first new UK vet school in 50 years."
Freda's responsibilities as Director of Education will now be split between Christine Warman, Head of Education, and Julie Dugmore, Head of Veterinary Nursing.
Freda said: "I have really enjoyed working with such a fascinating profession and I think that through working very closely with our colleagues in the vet schools, as well as with practising vets, veterinary education has made some significant advances. For example, there is more focus now on communication and professional skills and greater alignment of accreditation standards internationally, to name but two things.
"I am sad to leave but I know that the future of veterinary and veterinary nursing education has been left in the very safe hands of Christine and Julie and their respective teams."
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."